Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Marksans Pharma Limited (MARKSANS.NS)

216.03
-12.34
(-5.40%)
At close: April 25 at 3:30:03 PM GMT+5:30
All numbers in thousands
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
26,809,530
21,903,890
16,401,000
12,288,190
Total Liabilities Net Minority Interest
5,950,470
4,253,170
4,171,290
3,234,670
Total Equity Gross Minority Interest
20,859,060
17,650,720
12,229,710
9,053,520
Total Capitalization
20,650,540
17,451,620
12,022,700
8,864,950
Common Stock Equity
20,650,540
17,451,620
12,022,700
8,864,950
Capital Lease Obligations
2,149,700
813,570
694,860
153,630
Net Tangible Assets
19,607,930
16,358,760
11,136,760
8,194,730
Working Capital
14,726,430
13,343,110
8,449,820
6,038,520
Invested Capital
20,941,450
17,867,500
12,435,620
9,052,350
Tangible Book Value
19,607,930
16,358,760
11,136,760
8,194,730
Total Debt
2,440,610
1,229,450
1,107,780
341,030
Share Issued
453,163.75
453,163.75
409,313.70
409,313.70
Ordinary Shares Number
453,163.75
446,689.47
409,313.70
409,313.70
Treasury Shares Number
--
6,474.28
--
--
3/31/2021 - 7/19/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers